药石科技：10月29日召开董事会会议

Group 1 - The core point of the article is that Yaoshi Technology (SZ 300725) held its fourth board meeting on October 29, 2025, to review the proposal for revising the internal audit system [1] - For the year 2024, the revenue composition of Yaoshi Technology is entirely from drug molecular block research, accounting for 100.0% [1] - As of the report date, Yaoshi Technology has a market capitalization of 9.8 billion yuan [1] Group 2 - The A-share market has surpassed 4,000 points, marking a significant resurgence after a decade of stagnation, with technology leading the market transformation [1] - This shift indicates the beginning of a "slow bull" market pattern [1]